Timothy Stoltzfus Jost, J.D., is an Emeritus Professor at the Washington and Lee University School of Law. Jost is a member of the Institute of Medicine and a consumer liaison representative to the National Association of Insurance Commissioner. He is coauthor of a casebook, Health Law, used widely throughout the United States in teaching health law, and of a treatise and hornbook by the same name. He is also the author of Health Care at Risk: A Critique of the Consumer-Driven Movement; Health Care Coverage Determinations: An International Comparative Study; Disentitlement? The Threats Facing our Public Health Care Programs and a Rights-Based Response, and Readings in Comparative Health Law and Bioethics.
Jost is a contributing editor at Health Affairs and a frequent contributor to Health Affairs Blog. He has also written numerous articles and book chapters on health care regulation and comparative health law, including monographs on legal issues in health care reform for Georgetown’s O’Neill Center, the Fresh Thinking Project, the National Academy of Social Insurance and National Academy of Public Administration, and the New America Foundation and Urban Institute.
Recent Posts by Timothy Jost
Title XVIII of the 21st Century Cures Act creates a new vehicle for financing health coverage, the small employer health reimbursement arrangement. Also, a new report analyzes 18 options for reducing federal health care spending and a survey shows the percentage of persons with problems paying...
December 9, 2016 | Following the ACA
What are the ACA’s successes and failures? How might the new administration and Congress proceed with repealing and replacing it? What provisions might be adopted to replace the ACA and how might these provisions improve on, or undermine, the law's accomplishments?
Court Stays Cost-Sharing Reduction Payment Case, Giving Control To New Administration And Congress (Updated)
A court has stayed proceedings until at least Feb. 21, 2017 in a case brought by the House of Reps. challenging government payments to insurers to reimburse them for reducing cost sharing for lower-income marketplace enrollees. The suit is now the new administration and Congress’s responsibility.
As has been widely reported, President-elect Donald Trump has put forward the names of Tom Price for Secretary of Health and Human Services and Seema Verma for Administrator of the Centers for Medicare and Medicaid Services.
In light of the incoming new administration, the House is seeking to pause its litigation challenging cost-sharing reduction payments to insurers under the ACA. Simply stopping the payments could throw the individual insurance market into chaos, but a simple solution is available.
A judge has ruled for the government in the first decision on the merits in the nearly dozen insurer lawsuits seeking money allegedly owed them by the government under the ACA’s risk corridor program. OSHA also published a reg protecting premium and cost-sharing subsidy recipients from retaliation.
On November 10, CMS released its Draft 2018 Letter to Issuers in the Federally Facilitated Marketplace. President-Elect Donald Trump and the Republicans in control of Congress are committed to repealing the ACA, but until Congress actually acts, CMS has no option but to proceed normally.
Donald Trump and the Republican Congress cannot repeal the entire Affordable Care Act on “day one.” But they can repeal much of what the public thinks of as Obamacare through the budget reconciliation process, and President Trump can do much to interfere with the ACA on his own.
On November 2, the CDC’s National Center for Health Statistics released its quarterly report on health coverage, for January to June 2016. The dramatic reductions in the number of the uninsured that have occurred over the past three years as the ACA has been implemented have leveled off for 2016.
Today, November 1, the marketplaces opened for the 2017 open enrollment period. Other ACA-related developments include the filing of amicus briefs supporting the government in House v. Burwell.